- Home
- RWT vs PHVS Comparison
RWT vs PHVS Comparison
Compare RWT & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RWT
- PHVS
- Stock Information
- Founded
- RWT 1994
- PHVS 2015
- Country
- RWT United States
- PHVS Netherlands
- Employees
- RWT N/A
- PHVS N/A
- Industry
- RWT Real Estate Investment Trusts
- PHVS Biotechnology: Pharmaceutical Preparations
- Sector
- RWT Real Estate
- PHVS Health Care
- Exchange
- RWT Nasdaq
- PHVS Nasdaq
- Market Cap
- RWT 941.1M
- PHVS 1.0B
- IPO Year
- RWT 1995
- PHVS 2021
- Fundamental
- Price
- RWT $6.49
- PHVS $18.54
- Analyst Decision
- RWT Buy
- PHVS Strong Buy
- Analyst Count
- RWT 11
- PHVS 5
- Target Price
- RWT $7.98
- PHVS $40.60
- AVG Volume (30 Days)
- RWT 1.3M
- PHVS 66.5K
- Earning Date
- RWT 02-18-2025
- PHVS 11-13-2024
- Dividend Yield
- RWT 10.39%
- PHVS N/A
- EPS Growth
- RWT N/A
- PHVS N/A
- EPS
- RWT 0.55
- PHVS N/A
- Revenue
- RWT $268,358,000.00
- PHVS N/A
- Revenue This Year
- RWT N/A
- PHVS N/A
- Revenue Next Year
- RWT $19.05
- PHVS N/A
- P/E Ratio
- RWT $11.97
- PHVS N/A
- Revenue Growth
- RWT 234.24
- PHVS N/A
- 52 Week Low
- RWT $5.46
- PHVS $15.37
- 52 Week High
- RWT $8.15
- PHVS $33.00
- Technical
- Relative Strength Index (RSI)
- RWT 36.39
- PHVS 42.23
- Support Level
- RWT $6.39
- PHVS $18.18
- Resistance Level
- RWT $6.65
- PHVS $19.88
- Average True Range (ATR)
- RWT 0.19
- PHVS 1.17
- MACD
- RWT -0.03
- PHVS 0.08
- Stochastic Oscillator
- RWT 11.88
- PHVS 23.92
About RWT Redwood Trust Inc.
Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: the Residential Consumer Mortgage Banking segment consists of a mortgage loan conduit that acquires residential loans from third-party originators for subsequent sale to whole loan buyers, securitization through SEMT (Sequoia) private-label securitization program, or transfer into its investment portfolio, Residential Investor Mortgage Banking segment consists of a platform that originates and acquires business purpose lending loans for subsequent securitization, sale, or transfers into its investment portfolio, and Investment Portfolio segment consists of organic investments sourced through residential and business-purpose mortgage banking operations.
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.